The global medical device markets will reach approx. $380 bln in the year to come and the Middle East will contribute a mere $ 3.5 bln, e.g. less than 1 % to that total. Even in the “newly applied” definition of Middle East, including North Africa (MENA) but excluding Turkey in the west and Pakistan […]
Blog contribution by Emad Elmasr. The Middle East (ME) is often associated with many stereotypes and myths. The majority of European and American medical device companies entering the Middle East market are smart and well intentioned. However, they seem to make the same mistakes time after time.
Health care indicators in the GCC region are relatively good and have come a long way since only a few years back. Some of the most notable changes have been the decreased infectious disease rates and significant reductions in prenatal and maternal mortality.
Factors like rapid population growth, an expanding middle class, increased life expectancy rates and a government focus on the expansion of healthcare (i.e. turning the country into a medical tourism hub for the Middle East) all contribute to the promising healthcare market landscape in the UAE.